Home / Sell by State / California
Delivering Uncommon Results · California · Sell-Side M&A
California restricts the corporate practice of medicine more tightly than almost any other state, and two new laws that took effect January 1, 2026, just reset how a sale is built. A structure that would work in Texas can fail here, and a generalist broker who has not read SB 351 or AB 1415 can cost you months, or the deal itself. We represent California owners only, and we build your sale around the rules instead of around the buyer.
A confidential ballpark in under two minutes, no email required.
What A Generalist Broker Will Miss Here
California restricts the corporate practice of medicine more tightly than almost any other state. A non-physician, a private equity firm, or a general corporation cannot own a medical practice or control clinical decisions here. Only a physician-owned professional corporation can own and run the practice. That single rule is why a California sale is never an off-the-shelf company purchase, and why structure decides whether your deal closes and at what price.
The lawful path is a physician-owned professional corporation that keeps the clinical practice, paired with a management services organization that provides non-clinical business services for a fee. The MSO is what a non-physician buyer actually owns and capitalizes.
Bars private equity groups and hedge funds from controlling clinical matters, from diagnostic tests ordered to provider hiring and firing, and bans non-compete and non-disparagement clauses in these management arrangements. Older agreements may need rework before close.
Expands premerger notice to California's Office of Health Care Affordability. MSOs, private equity groups, hedge funds, and new acquisition entities are now noticing entities, which can add a notice period and a Cost and Market Impact Review to larger deals.
The California Attorney General has challenged agreements that let an MSO force a change of the physician-owner, arguing they hand the corporation impermissible control. Structures that worked a few years ago can fail today.
SB 351 and AB 1415 took effect January 1, 2026, and OHCA materiality thresholds are still in agency rulemaking. Treat this as current law plus active regulatory change, accurate as of June 2026, not a settled rule that never moves. Sources: Morgan Lewis and Sidley Austin healthcare-transactions analyses (linked in our sources).
| Metric | Figure | Note |
|---|---|---|
| California population | ~39.4M | US Census Bureau estimate |
| Most populous US state | #1 | Largest buyer-demand base by population |
| State-level med spa count | Not published | AmSpa reports national totals only |
AmSpa's State of the Medical Spa Industry report publishes a national med spa count only and includes no state-by-state breakdown or ranking. Population figure is a US Census Bureau estimate.
Market Reality
AmSpa's State of the Medical Spa Industry report publishes a national med spa count only, with no state-by-state breakdown or ranking, so we will not cite an uncitable California figure. What is verifiable is scale: California is the most populous state in the country at roughly 39.4 million residents, and that population base is exactly why national platforms keep buying here.
Run my numbers →See Your Number First
A confidential ballpark in under two minutes. No email required to see your range. The estimate is generated on your device. Nothing is stored or sent unless you choose to continue.
Step 1 · Instant ballpark
Estimated enterprise value
Practices like yours trade around 2.6x – 5.3x adjusted earnings.
What raises your number
What lowers your number
Step 2 · What you receive when you continue
Your custom valuation report. Comparable transactions, your likely buyer pool, and timing analysis.
Your buyer-readiness scorecard. The specific moves that raise your multiple before you go to market.
A confidential 30-minute strategy call with Bill Walker. No obligation, no pressure.
Your information is never shared, and we have never broken a client's confidentiality.
Estimate only. A ballpark from limited inputs plus published industry M&A benchmarks.
What Moves Value Here
No California-specific sale multiple is published, and we will not invent one. The honest anchor is the national vertical range already on our med spa, cosmetic dermatology, and plastic surgery hubs. What changes a California seller's realized value is how the deal has to be built and how cleanly it clears the new 2026 rules.
Because the deal runs through a friendly-PC / MSO wrap, a buyer is paying for the MSO's management-fee stream and the durability of the PC relationship, not a clean equity purchase. A cleanly structured practice transacts faster and holds its multiple.
Map my structure →AB 1415 notice and a possible Cost and Market Impact Review add time and deal risk to larger California transactions, and buyers price that in. SB 351 forces management and employment agreements to be cleaned up before close.
See the 2026 rules →California is the most populous state in the country, and multiple national platforms are actively consolidating here. That demand is what supports the national range for a well-prepared seller.
Who is buying →We reference the national vertical multiple range published on our practice-type hubs. We do not publish a California-specific multiple, because none exists in a citable, defensible form. Your real range comes from a confidential, practice-specific analysis of your earnings, your structure, and your comps.
Who Is Actually Buying in California
A California seller does not depend on one local acquirer. Well-capitalized national platforms and PE-backed MSOs buy here, and there is a documented, in-state proof point: Schweiger Dermatology Group's acquisition of California Skin Institute, a large California dermatology and cosmetic-surgery group, recorded in a California Office of Health Care Affordability material-change transaction notice. We will never name a "local buyer" that does not exist.
Detail bars are redacted by design. Every name and activity claim on this board is published from verifiable records; anything beyond the public record stays confidential. Schweiger / California Skin Institute is the in-state proof point, documented in a California OHCA material-change notice. The other platforms are named as national consolidators active in the dermatology and aesthetics vertical, per Physician Growth Partners and CT Acquisitions market updates. No local-only buyer is asserted.
California Sale FAQ
Not the way they would buy a normal business. California restricts the corporate practice of medicine, so a non-physician investor cannot own a medical practice or control clinical decisions. The lawful path is the friendly-PC and MSO structure: a physician-owned professional corporation keeps the clinical practice, and a separate management services organization, the part the investor owns and funds, contracts to provide non-clinical business services for a fee. That is why a California sale is a structured transaction, not a simple stock or asset sale.
Both took effect January 1, 2026. SB 351 bars private equity groups and hedge funds from controlling clinical matters such as diagnostic tests ordered, referral and consultation necessity, patient volume per physician, medical-record content, provider hiring and firing based on clinical competency, payer-contract terms, billing and coding decisions, and medical-equipment selection. It also bans non-compete and non-disparagement clauses in these management arrangements. AB 1415 expands premerger notice to California’s Office of Health Care Affordability and names MSOs, private equity groups, hedge funds, and newly formed acquisition entities as noticing entities, which can add a notice period and a Cost and Market Impact Review to a deal. Materiality thresholds are still in agency rulemaking, so this is current law plus active regulatory change.
No. There is no published California-specific multiple, and we will not quote one. What we use is the national vertical range for your practice type, then we explain how California law and market move structure and value. A practice that is already cleanly structured for compliance, with a defensible MSO agreement and no SB 351-offending clauses, transacts faster and holds its value. A practice that is not invites re-trading and discounts. Your real number comes from a confidential, practice-specific analysis.
Demand is national and verifiably present in California. Schweiger Dermatology Group acquired California Skin Institute, a large California dermatology and cosmetic-surgery group, with the transaction recorded in a California Office of Health Care Affordability material-change notice. Other national consolidators active in the broader dermatology and aesthetics vertical include Epiphany Dermatology, Pinnacle Dermatology, DermCare, and Water’s Edge. The accurate picture is well-capitalized national platforms and PE-backed MSOs buying in California, not a single local acquirer.
California is one of the largest aesthetic markets in the country. AmSpa’s State of the Medical Spa Industry report publishes a national med spa count only, with no state-by-state breakdown or ranking, and we will not cite an uncitable California figure. What is verifiable is scale: California is the most populous state in the country, with roughly 39.4 million residents per US Census Bureau estimates, a base large enough on its own to support sustained buyer demand.
Yes, unless and until you choose to tell people. We run every process under strict confidentiality, with confidentiality agreements, secure data rooms, staged disclosure, and a vetted buyer process. Premature disclosure can unsettle staff, shake patient confidence, and weaken your negotiating position, so you decide what is shared, with whom, and when. Note that some larger transactions can require advance notice to a state agency under AB 1415, and we plan for that openly with you as part of the structure.
Match Your Practice Type
How recurring and membership revenue, provider capacity, and key-person risk set a med spa's value, paired with the California structure work above.
Med spa sell-side →Where California's largest in-state derm activity is happening, and how a cosmetic derm practice is valued for sale.
Cosmetic derm sell-side →The valuation and deal-structure work for a surgical aesthetic practice, mapped to California's corporate-practice rules.
Plastic surgery sell-side →By Metro
Compare every market on the Sell by State directory.
Where Los Angeles deal activity is concentrated, mapped to California structure.
Selling in Los Angeles →Our home market in La Jolla, and the verified buyers active here.
Selling in San Diego →Three PE platforms are consolidating the Bay Area. Who, and how a sale is built.
Selling in San Francisco Bay Area →The Newport Beach and Irvine corridor, and the KKR-backed buyer active here.
Selling in Orange County →Capital-region deal activity, mapped to California structure.
Selling in Sacramento →
Who you work with
Bill Walker founded Aesthetic Brokers after leading mergers and acquisitions for a large private-equity-backed healthcare services organization. Before that he flew for the Marine Corps at the Presidential Helicopter Squadron and commanded a squadron in combat. He knows how an investor values a practice, and how to make sure that value lands with you, not the buyer.
Talk with Bill about your practiceStart with a confidential, two-minute read on where you stand.
